Gene · 3078
Papers1,634
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,634
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pulmonary Renal Syndrome due to Atypical HUS in a Young Gentleman. | Indian J Nephrol | 2023 | 37781545 | PubTator, text mining | PubMed |
| Complement System Proteins in the Human Aqueous Humor and Their Association with Primary Open-Angle Glaucoma. | J Pers Med | 2023 | 37763167 | PubTator, text mining | PubMed |
| Immunosuppressive Therapy of Antibody-Mediated aHUS and TTP. | Int J Mol Sci | 2023 | 37762692 | PubTator, text mining | PubMed |
| Cryo-EM and biochemical analyses of the nucleosome containing the human histone H3 variant H3.8. | J Biochem | 2023 | 37757444 | PubTator, text mining | PubMed |
| Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy. | Drugs | 2023 | 37747686 | PubTator, text mining | PubMed |
| Genetic investigation of Nordic patients with complement-mediated kidney diseases. | Front Immunol | 2023 | 37744338 | PubTator, text mining | PubMed |
| The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment. | Front Pharmacol | 2023 | 37731742 | PubTator, text mining | PubMed |
| Thrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology. | BMC Nephrol | 2023 | 37730583 | PubTator, text mining | PubMed |
| Daratumumab in the treatment of C3 glomerulopathy with monoclonal gammopathy: a case report and literature review. | Front Med (Lausanne) | 2023 | 37724175 | PubTator, text mining | PubMed |
| Challenges in IgA Nephropathy Management: An Era of Complement Inhibition. | Kidney Int Rep | 2023 | 37705895 | PubTator, text mining | PubMed |
| Modeling the Magnetoelectric Composites in a Wide Frequency Range. | Materials (Basel) | 2023 | 37687506 | PubTator, text mining | PubMed |
Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential Therapeutic Targets in Human IDH Mutant High-Grade Gliomas. | J Proteome Res | 2023 | 37651309 | PubTator, text mining | PubMed |
| Mesangial C3 Deposition, Complement-Associated Variant, and Disease Progression in IgA Nephropathy. | Clin J Am Soc Nephrol | 2023 | 37651123 | PubTator, text mining | PubMed |
| Novel pH-activatable NIR fluorogenic spray mediated near-instant and precise tumor margins identification in human cancer tissues for surgical resection. | Theranostics | 2023 | 37649597 | PubTator, text mining | PubMed |
| RGS2 and female common diseases: a guard of women's health. | J Transl Med | 2023 | 37649067 | PubTator, text mining | PubMed |
| Complement System Activation Is a Plasma Biomarker Signature during Malaria in Pregnancy. | Genes (Basel) | 2023 | 37628675 | PubTator, text mining | PubMed |
| Thrombosis in Multisystem Inflammatory Syndrome Associated with COVID-19 in Children: Retrospective Cohort Study Analysis and Review of the Literature. | Biomedicines | 2023 | 37626703 | PubTator, text mining | PubMed |
| Cancer-on-chip: a 3D model for the study of the tumor microenvironment. | J Biol Eng | 2023 | 37592292 | PubTator, text mining | PubMed |
| Rare genetic variants involved in multisystem inflammatory syndrome in children: a multicenter Brazilian cohort study. | Front Cell Infect Microbiol | 2023 | 37588055 | PubTator, text mining | PubMed |
| The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications. | J Mol Med (Berl) | 2023 | 37584739 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3078/papers?page=7